UVEAL MELANOMA, RECURRENT
Clinical trials for UVEAL MELANOMA, RECURRENT explained in plain language.
Never miss a new study
Get alerted when new UVEAL MELANOMA, RECURRENT trials appear
Sign up with your email to follow new studies for UVEAL MELANOMA, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection therapy targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests an experimental drug called ONM-501, injected directly into tumors, either alone or with a second drug (cemiplimab), in people with advanced solid tumors or lymphomas that have not responded to standard treatments. The main goals are to find the safes…
Matched conditions: UVEAL MELANOMA, RECURRENT
Phase: PHASE1 • Sponsor: OncoNano Medicine, Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
New pill shows promise for advanced eye cancer
Disease control Recruiting nowThis study tests an experimental drug, NBM-BMX, in people with metastatic uveal melanoma—a rare eye cancer that has spread to other organs. The goal is to find the best dose, check side effects, and see if the drug can shrink tumors or slow the disease. Participants take the drug…
Matched conditions: UVEAL MELANOMA, RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Novelwise Pharmaceutical Corporation • Aim: Disease control
Last updated Jun 08, 2026 13:07 UTC